Oops, you're using an old version of your browser so some of the features on this page may not be displaying properly.

MINIMAL Requirements: Google Chrome 24+Mozilla Firefox 20+Internet Explorer 11Opera 15–18Apple Safari 7SeaMonkey 2.15-2.23

Poster lunch

1485 - Metabolic pathways promoting tumorigenesis in fibroblasts lacking thrombospondin 1 (557P)

Date

18 Nov 2017

Session

Poster lunch

Presenters

Nicole Cumbo

Citation

Annals of Oncology (2017) 28 (suppl_10): x173-x176. 10.1093/annonc/mdx679

Authors

N. Cumbo, V. Kalter, A. Hedge, L. Thomas, J. Quintana, I. Pinkerton, L. Gutierrez

Author affiliations

  • Biology, Wilkes University, 18766 - Wilkes Barre/US
More

Resources

Abstract 1485

Background

Thrombospondin 1 (TSP-1) is a matricellular protein involved in angiogenesis, inflammation and carcinogenesis. Colonic tumors developed in TSP-1 deficient (TSP-1-/-) mice after injections with axoxymethane (AOM) and induction of colitis by dextran sodium sulphate (DSS) showed accelerated angiogenesis and proliferation. Interestingly, fibroblasts isolated from these AOM/DSS tumors were able to develop fibrosarcomas when they were subcutaneously re-injected in TSP-1-/- mice. This study aims to reveal the metabolites and pathways promoting the malignant differentiation of these fibroblasts. These results might contribute to a better understanding of the role of fibroblasts within the tumor microenvironment.

Methods

Wild type (WT) and TSP-1-/- fibroblasts previously isolated from AOM/DSS tumors were subcutaneously injected in the flank of the mice. TSP-1-/- tumors (n = 5) and skin and subcutaneous tissues surrounding the lesions (n = 5) were collected for metabolomic analyses. As WT fibroblasts are unable to develop into tumors, the skin and subcutaneous tissues of the injection sites (n = 5) were collected as controls. Targeted analysis and absolute quantitation (3‐point calibration) was performed by using CE‐TOFMS and CE‐QqQMS. Statistical analysis reporting average, ratio and p‐value were obtained using the StatSuite software (Human Metabolome Technologies, Boston, MA)

Results

A total of 116 metabolites were analysed and quantified. Tumors showed an increase in metabolites related with oxidative stress and differentiation of stromal cells. Intermediaries of the nitric oxide pathway and inhibitors of proliferation were depleted. Skin and subcutaneous tissue surrounding fibrosarcomas exhibited an excess of metabolites related with glycolysis and oxidation/reduction pathways; however, the same metabolites were decreased in WT skin.

Conclusions

This study uncovers key metabolic pathways in cancer and underlines the importance of stromal cells and matricellular proteins such as TSP-1 in carcinogenesis.

Clinical trial identification

Legal entity responsible for the study

Linda Gutierrez

Funding

Wilkes University

Disclosure

All authors have declared no conflicts of interest.

This site uses cookies. Some of these cookies are essential, while others help us improve your experience by providing insights into how the site is being used.

For more detailed information on the cookies we use, please check our Privacy Policy.

Customise settings
  • Necessary cookies enable core functionality. The website cannot function properly without these cookies, and you can only disable them by changing your browser preferences.